Patents by Inventor Kfir Baruch UMANSKY

Kfir Baruch UMANSKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230173023
    Abstract: A method of treating an ischemic heart disease in a subject in need thereof is provided. The method comprises administering to the subject a therapeutically effective amount of Agrin in an anterograde intracoronary manner, thereby treating the ischemic heart disease in the subject.
    Type: Application
    Filed: February 7, 2023
    Publication date: June 8, 2023
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Eldad Tzahor, Kfir Baruch Umansky, Rabea Hinkel, Christian Kupatt
  • Publication number: 20200397853
    Abstract: A method of treating a heart disease in a subject in need thereof is provided. The method comprises administering to the subject a therapeutically effective amount of an agent selected from the group consisting of Copolymer 1, a Copolymer 1-related polypeptide and a Copolymer 1-related peptide, thereby treating the heart disease.
    Type: Application
    Filed: September 9, 2020
    Publication date: December 24, 2020
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Eldad TZAHOR, Ruth ARNON, Rachel SARIG, Rina AHARONI, Kfir Baruch UMANSKY
  • Publication number: 20200306343
    Abstract: A method of treating an ischemic heart disease in a subject in need thereof is provided. The method comprises administering to the subject a therapeutically effective amount of Agrin in an anterograde intracoronary manner, thereby treating the ischemic heart disease in the subject.
    Type: Application
    Filed: June 3, 2020
    Publication date: October 1, 2020
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Eldad TZAHOR, Kfir Baruch UMANSKY, Rabea HINKEL, Christian KUPATT
  • Patent number: 10017574
    Abstract: A method of potentiating cardiac regeneration with neuregulin treatment in a subject in need thereof. The method comprising administering to the subject a therapeutic effective amount of an agent which upregulates activity or expression of ErbB-2, thereby potentiating cardiac regeneration with neuregulin treatment.
    Type: Grant
    Filed: May 5, 2016
    Date of Patent: July 10, 2018
    Assignees: Yeda Research and Development Co. Ltd., Victor Chang Cardiac Research Institute
    Inventors: Eldad Tzahor, Gabriele Matteo D'Uva, Rachel Sarig, Alla Aharonov, Richard Paul Harvey, Kfir Baruch Umansky
  • Publication number: 20160326250
    Abstract: A method of potentiating cardiac regeneration with neuregulin treatment in a subject in need thereof. The method comprising administering to the subject a therapeutic effective amount of an agent which upregulates activity or expression of ErbB-2, thereby potentiating cardiac regeneration with neuregulin treatment.
    Type: Application
    Filed: May 5, 2016
    Publication date: November 10, 2016
    Inventors: Eldad TZAHOR, Gabriele Matteo D'UVA, Rachel SARIG, Alla AHARONOV, Richard Paul HARVEY, Kfir Baruch UMANSKY